The global indwelling catheters market size was valued at USD 1,490 million in 2021. It is expected to reach USD 3,260 million by 2030, growing at a CAGR of 9.1% during the forecast period (2022-2030).
The indwelling catheters use to urine from the bladder is drained into a collection bag, which are soft and flexible tubes. In addition to other medical conditions, indwelling catheters treat urine retention, incontinence, and other health issues. The most common type is a Foley catheter, featuring a flexible tube with an expanded balloon at the end that holds it inside the bladder. Another kind is the suprapubic catheter, which is inserted by surgery into the bladder through an abdominal wall opening. In order to lower the risk of problems, catheters should be removed as soon as they are no longer required. Depending on the patient's needs and health, alternative treatment strategies may also be examined.
The main reasons projected to propel the global market for indwelling catheters during the forecast period are an increase in urinary disorders, a rise in the world's elderly population, and an increase in surgical procedures. Additionally, the American Academy of Family Physicians (AAFP) reports that every year in the U.S., more than 250,000 surgical treatments for benign prostatic hyperplasia (BPH) are carried out, resulting in 2 million office visits. This is projected to increase demand for indwelling catheters in the upcoming years.
|Market Size||USD 3,260 million by 2030|
|Fastest Growing Market||Asia-Pacific|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
Rising Prevalence of Urological Diseases
A urinary system infection, comprising the urethra, bladder, ureters, and kidney, is a urinary tract infection (UTI). According to the National Healthcare Safety Network, foley catheters are necessary for the most common urological ailment, UTIs. Furthermore, 15 to 25 percent of hospitalized patients have an indwelling catheter each year, according to data published by the Centers for Disease Control and Prevention (CDC). According to the American Academy of Family Physicians (AAFP), 4.5 to 6.8 males per 1,000 experience urinary retention yearly. If the bladder is merely drained, 70% of men will likely experience recurrent urine retention within a week despite using foley catheters, necessitating a foley catheter. According to a recent AAPF study, male urine retention is associated with benign prostatic hyperplasia (BPH) in approximately 53% of instances. Additionally, BPH is responsible for over 250,000 surgical procedures and over 2 million doctor visits each year in the United States, which leads to the need for foley catheters. Similarly, neurological conditions like multiple sclerosis, cerebral palsy, spinal cord injury, and strokes can also cause urological conditions, which increases the demand for indwelling catheters.
Increase in Product Launches
Key players in the global market for indwelling catheters include Cardinal Health, Inc., Coloplast Corp., Becton, Teleflex Incorporated, Cook Medical, Bactiguard, SunMed, B. Braun, and others. These companies engage in R&D to produce distinctive goods to broaden their product portfolio and customer base in the global market for indwelling catheters. In August 2018, Bactiguard released Tiemann Tip and Silicone Female urinary indwelling catheters as line extensions to BIP Foley Catheters. These catheters are used to catheterize males and females. Furthermore, the Bardex IC catheter (offered by BD Bard) has a silver-alloy coating (a gold and palladium coating containing metallic silver, covered by a layer of hydrogel). In contrast, the Dover silver catheter (offered by Cardinal Health) is coated with a hydrogel containing silver ions, reducing catheter-associated urinary tract infections. These launches enabled the company to grow its product portfolio and strengthen its position in the global indwelling catheters market.
Increase in Catheter-Associated Infections
Although indwelling catheters enhance the patient's health and quality of life, the danger of infections linked to the catheter prevents their widespread use. According to NHSN (National Healthcare Safety Network), 75% of hospital urinary tract infections are associated with catheters. However, the rising number of patient complications related to indwelling catheters is a crucial inhibitor to the growth of the global indwelling catheter market. Long-term urinary catheter users are likely to experience complications like bladder muscle spasms. Additionally, bladder spasms might cause urine to flow around the catheter, making the patient feel uneasy. The catheter can become blocked by mucus, protein deposits, or microscopic mineral crystals, which momentarily halt the urine flow.
Similarly, the CDC reported that catheter misuse is the primary cause of more than 40% of hospital-acquired illnesses, including urinary tract infections. The CDC has released recommendations about using catheters for the proper indications and has advised healthcare professionals to remove indwelling catheters when they are no longer required to reduce the prevalence of these infections. This has also negatively affected patients' perceptions, and it is anticipated that it will somewhat restrict the use of indwelling catheters in medical facilities.
Increase in Geriatric Population
Older people are more likely to develop chronic conditions like prostate cancer, kidney stones, and UTIs. As a result, there is a greater demand for healthcare services among older adult populations. Medicare and Medicaid are the primary third-party payers for the costs associated with older individuals' healthcare in the United States. In addition, as per National Health Expenditure Accounts (NHEA), the total healthcare expenditure in the U.S. was around 4.6% in 2018, i.e., about USD 3.6 trillion or USD 11,172 per person, which is anticipated to further drive the market growth during the forecast period.
The global indwelling catheters market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant contributor to the global indwelling catheters market and is estimated to grow at a CAGR of 7.4% during the forecast period. An increase in the prevalence of urological conditions, such as urine retention, which the American Academy of Family Physicians (AAFP) reports has an annual incidence of 4.5 to 6.8 per 1,000 men. If the bladder is drained despite the insertion of a foley catheter, 70% of men will likely experience recurrent urine retention within a week, necessitating the use of a foley catheter. Increased initiatives by research institutes and organizations for improving medical facilities and services further lead to market growth.
The Asia-Pacific is projected to grow at a CAGR of 11.3% and reach USD 1,050 million during the forecast period. Healthcare infrastructure and expenditures have improved in emerging markets such as India and China to overcome the unmet catheter needs, which is expected to boost market growth. In addition, the major driving factors are the increasing development of medical devices, pharmaceutical and biotechnology industries, the increasing prevalence of urologic diseases, and growing demand from emerging markets. Japan prioritizes healthcare as part of its national development plan as regional and central governments contribute to upgrading healthcare facilities. Furthermore, according to OECD statistics, Australia spent about 9.1% of its GDP on healthcare in 2017.
Europe is the third largest region in the global indwelling catheters market. Germany is anticipated to expand as the prevalence of UTIs rises. Infections related to healthcare affect almost 4 million individuals annually in the European Union, and 20% to 30% of these infections are thought to be preventable. Healthcare-associated UTIs (HAUTIs) represent the giant subtype among all healthcare-associated infections. An increase in R&D activities for innovating newer products and business expansion by market players are expected to propel the market.
The global indwelling catheter market is segmented by product, material, coating type, and application.
Based on the product, the global indwelling catheters market is categorized into 2-way catheters, 3-way catheters, and 4-way catheters.
The 2-way catheters segment is the highest contributor to the market and is estimated to grow at a CAGR of 10% during the forecast period. The increasing prevalence of urological diseases and the rise in the geriatric population are crucial factors driving the global indwelling catheter market. Moreover, increasing cases of benign prostate hyperplasia, kidney stones, urethra blockages, and other urinary disorders due to an unhealthy diet and sedentary lifestyle are expected to propel the global indwelling catheter market growth.
Based on material, the global indwelling catheters market is categorized into latex and silicone.
The silicone segment is the highest contributor to the market and is estimated to grow at a CAGR of 9.8% during the forecast period. The major driving factors of silicone indwelling catheters are increasing development in the development of medical devices industry, pharmaceutical, and biotechnology industries, increasing prevalence of urologic diseases, and growing demand from emerging markets.
The factors driving the latex indwelling catheters market include the increasing prevalence of urinary bladder diseases, high demand for minimally invasive surgeries, and a large pool of geriatric population. The market is expected to expand due to introducing new beneficial goods to reduce infections, such as silicone-coated latex foley catheters resistant to chemical attacks and temperature variations.
Based on coating type, the global indwelling catheters market is categorized into hydrogel coating, silver alloy coating, silicone-elastomer, and others.
The hydrogel coating segment is the highest contributor to the market and is expected to grow at a CAGR of 10% during the forecast period. Bonded hydrogel-coated latex catheters may last longer than silicone catheters because their hydrogel coating reduces bacterial adherence and mucosal friction. Hydrogels or polymers coat the catheter and absorb water to create a slick exterior, protecting the patient's urethra from injury. Gram-positive and gram-negative bacteria are less likely to cling to catheters due to these features, potentially serving as potential barriers to bacterial infection. Hence, it will boost the demand for hydrogel coating catheters and further fuel the market growth.
The silicone-elastomer segment is the second largest as it treats various neurological, urological, and other illnesses with better clinical procedures and cutting-edge technologies. Healthcare organizations worldwide place a high priority on diagnosis, prevention, and treatment. In addition, urological diseases, kidney stones, UTIs, diabetes, and a rising desire for more minor invasive procedures all contribute to the market expansion for indwelling catheters.
Based on application, the global indwelling catheters market is segmented into post-surgical care, critical care, urinary incontinence, and benign prostate hyperplasia.
The post-surgical care segment is the highest contributor to the market and is anticipated to grow at a CAGR of 9% during the forecast period. Postoperative urinary retention (POUR) refers to patients' inability to void urine despite a full bladder after the surgical intervention in the postoperative period. The development of POUR may be caused by several factors, including the type of anesthetic, the procedure's complexity and length, underlying comorbidities, and medications taken during the operation. As a result, urinary catheterization is frequently performed during the postoperative course of surgery patients. The drainage strategy selected for each patient is determined by age, pre-operative voiding mechanism, and surgical treatment, contributing to market expansion.
The benign prostate hyperplasia segment is the fastest growing. The quality of life is negatively impacted by BPH, according to one-third of men over 50 who have the condition. Around 30 million men worldwide experience BPH symptoms, including up to 14 million men in the United States. Increased awareness of urological illnesses such as benign prostatic hyperplasia and prostate cancer, as well as an increase in the number of cases worldwide, are other factors driving the market's expansion.